Blandine de Lauzon-Guillain1, Jonathan Y Bernard2,3, Pauline Martinot2, Moufidath Adjibade2, Marion Taine2, Camille Davisse-Paturet2, Sandrine Lioret2, Marie-Aline Charles2,4. 1. Université de Paris, Centre for Research in Epidemiology and Statistics (CRESS), Inserm, INRAE, 75004, Paris, France. blandine.delauzon@inserm.fr. 2. Université de Paris, Centre for Research in Epidemiology and Statistics (CRESS), Inserm, INRAE, 75004, Paris, France. 3. Agency for Science, Technology and Research (A*STAR), Singapore Institute for Clinical Sciences (SICS), Singapore, Singapore. 4. Unité mixte Inserm-Ined-EFS ELFE, Ined, 93322, Aubervilliers, France.
Abstract
PURPOSE: For decades, consistent associations between breastfeeding and children's neurodevelopment have been attributed to breastmilk content in long-chain polyunsaturated fatty acids (LC-PUFAs). However, the beneficial effect of LC-PUFA enrichment of infant formula on neurodevelopment remains controversial. This study examined the association of LC-PUFA enrichment of infant formulas with neurodevelopment up to age 3.5 years. METHODS: Analyses were based on 9372 children from the French nationwide ELFE birth cohort. Monthly from 2 to 10 months, parents declared their infant's feeding mode, including breastfeeding and the name of the infant formula, which allowed for identifying formulas enriched in arachidonic (ARA), eicosapentaenoic (EPA) and/or docosahexaenoic (DHA) acids. Neurodevelopment was assessed at age 1 and 3.5 years with the Child Development Inventory (CDI-1 and CDI-3.5); at 2 years with the MacArthur-Bates Communicative Development Inventories (MB-2); and at 3.5 years with the Picture Similarities subtest of the British Ability Scale (BAS-3.5). Associations were assessed by linear regression adjusted for any breastfeeding duration and main confounding factors, including socioeconomic characteristics. RESULTS: One-third of formula-fed infants consumed LC-PUFA-enriched formulas. Most of these formulas were enriched in both DHA and ARA, and about 10% of infants consumed formula further enriched in EPA. LC-PUFA enrichment of infant formula was not associated with neurodevelopmental scores at age 1 (CDI-1, - 0.16 [- 0.39, 0.07]), age 2 (MB-2, 0.78 [- 0.33, 1.89]), or age 3.5 (CDI-3.5, - 0.05 [- 0.27, 0.17]; BAS-3.5, - 0.93 [- 2.85, 0.98]). CONCLUSION: In the ELFE study, LC-PUFA enrichment of infant formula was not associated with neurodevelopmental scores up to 3.5 years.
PURPOSE: For decades, consistent associations between breastfeeding and children's neurodevelopment have been attributed to breastmilk content in long-chain polyunsaturated fatty acids (LC-PUFAs). However, the beneficial effect of LC-PUFA enrichment of infant formula on neurodevelopment remains controversial. This study examined the association of LC-PUFA enrichment of infant formulas with neurodevelopment up to age 3.5 years. METHODS: Analyses were based on 9372 children from the French nationwide ELFE birth cohort. Monthly from 2 to 10 months, parents declared their infant's feeding mode, including breastfeeding and the name of the infant formula, which allowed for identifying formulas enriched in arachidonic (ARA), eicosapentaenoic (EPA) and/or docosahexaenoic (DHA) acids. Neurodevelopment was assessed at age 1 and 3.5 years with the Child Development Inventory (CDI-1 and CDI-3.5); at 2 years with the MacArthur-Bates Communicative Development Inventories (MB-2); and at 3.5 years with the Picture Similarities subtest of the British Ability Scale (BAS-3.5). Associations were assessed by linear regression adjusted for any breastfeeding duration and main confounding factors, including socioeconomic characteristics. RESULTS: One-third of formula-fed infants consumed LC-PUFA-enriched formulas. Most of these formulas were enriched in both DHA and ARA, and about 10% of infants consumed formula further enriched in EPA. LC-PUFA enrichment of infant formula was not associated with neurodevelopmental scores at age 1 (CDI-1, - 0.16 [- 0.39, 0.07]), age 2 (MB-2, 0.78 [- 0.33, 1.89]), or age 3.5 (CDI-3.5, - 0.05 [- 0.27, 0.17]; BAS-3.5, - 0.93 [- 2.85, 0.98]). CONCLUSION: In the ELFE study, LC-PUFA enrichment of infant formula was not associated with neurodevelopmental scores up to 3.5 years.
Authors: Jonathan Y Bernard; Martine Armand; Hugo Peyre; Cyrielle Garcia; Anne Forhan; Maria De Agostini; Marie-Aline Charles; Barbara Heude Journal: J Pediatr Date: 2017-01-09 Impact factor: 4.406
Authors: Erik Lykke Mortensen; Kim Fleischer Michaelsen; Stephanie A Sanders; June Machover Reinisch Journal: JAMA Date: 2002-05-08 Impact factor: 56.272
Authors: Cesar G Victora; Rajiv Bahl; Aluísio J D Barros; Giovanny V A França; Susan Horton; Julia Krasevec; Simon Murch; Mari Jeeva Sankar; Neff Walker; Nigel C Rollins Journal: Lancet Date: 2016-01-30 Impact factor: 79.321
Authors: Michael S Kramer; Frances Aboud; Elena Mironova; Irina Vanilovich; Robert W Platt; Lidia Matush; Sergei Igumnov; Eric Fombonne; Natalia Bogdanovich; Thierry Ducruet; Jean-Paul Collet; Beverley Chalmers; Ellen Hodnett; Sergei Davidovsky; Oleg Skugarevsky; Oleg Trofimovich; Ludmila Kozlova; Stanley Shapiro Journal: Arch Gen Psychiatry Date: 2008-05
Authors: Mandy B Belfort; Sheryl L Rifas-Shiman; Ken P Kleinman; Lauren B Guthrie; David C Bellinger; Elsie M Taveras; Matthew W Gillman; Emily Oken Journal: JAMA Pediatr Date: 2013-09 Impact factor: 16.193